This article was published orginally in Fortune and is authored by Arthur Allen and republished with permission from KHN (@khnews).
The drug industry, patient advocates,...
After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.